URL copied
Bharat Biotech submitted 90% of documentation to WHO for emergency use listing for Covaxin
Bharat Biotech International Limited (BBIL) has conveyed to the government that it has submitted 90 per cent of the documentation to the World Health Organisation for obtaining an emergency use listing for the Covaxin vaccine and the remaining details will be supplied next month, sources said on Monday.
In a separate development, the BBIL is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States, sources said.
The issue of the WHO s authorisation for emergency use listing (EUL) for Covaxin was discussed at a meeting between the top brass of the BBIL and senior officials of the Ministry of Health, Department of Biotechnology and the Ministry of External Affairs. Â
WHO Given 90% Documents For Covaxin s Emergency Listing: Bharat Biotech WHO Given 90% Documents For Covaxin s Emergency Listing: Bharat Biotech The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government.
Covaxin has already received regulatory approval from 11 countries (File)
New Delhi:
Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday.
The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government during a discussion on obtaining the World Health Organisation s authorisation for emergency use listing for Covaxin, sources said.
CIC Asks Health Ministry to Proactively Disclose Information on COVID-19 in Public Interest
According to the government s response to an RTI query, more than six crore vaccine doses were procured through the PM Cares Fund.
Beneficiaries wait in a queue to recieve COVID-19 vaccine dose at a vaccination centre in Jalandhar, Monday, May 17, 2021. Photo: PTI
Health10 hours ago
New Delhi: The Central Information Commission has advised the Ministry of Health and Family Welfare to âensure that maximum information [on COVID-19] which serves larger public interest, is proactively disclosed, to enhance transparency and dissemination of correct informationâ.
Dealing with two cases in which the ministry was accused of withholding information regarding various aspects of the COVID-19 vaccines and its impact on people, the panel chief, Y.K. Sinha, said giving out information on time would âobviate the need for filing of RTI cases by citizens on matters of such vital importance�
Monthly Production Of Covishield And Covaxin To Shoot Up To 10 Crore And 7 8 Crore Respectively By August 2021 swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Russia s Sputnik V Covid vax to be available in market from next week: Govt
By IANS |
4 Views
New Delhi, May 13 : The Union Health Ministry on Thursday announced that Russia s Sputnik V, the vaccine against the Covid-19 pandemic, will be available in markets across the country early next week.
The announcement comes 12 days after the first consignment of 150,000 doses of the Sputnik V vaccine landed in Hyderabad from Russia. Sputnik V is developed by Russia s Gamaleya National Center. It will be the third vaccine to be cleared for use in India at a time when the country is in the grip of an intense second wave and demand for vaccines has shot up.